Lenskart Solutions Limited (LENSKART.BO) stock analysis

In our weekly check, Lenskart Solutions Limited is graded B (A to F). Of 19 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 2.

About Lenskart Solutions Limited

Lenskart Solutions Limited is a Healthcare company (Medical - Specialties) based in India, listed on BSE as LENSKART.BO.

What our checks show for LENSKART.BO

Red flags

• Operating profit does not cover the interest bill (0x): interest is paid from cash or new debt.
• The price is 178 times earnings (P/E): the market already pays for a lot of future growth.

Warning signs

• The net margin is only 5.6%: little room if costs rise.
• Return on capital (ROCE) is only 7.5%.

Strengths

• Debt is low: 0.35x equity.
• Operating cash flow is 3.48x net profit: the profit arrives as real cash.
• Analysts expect earnings per share to grow about 49.3% a year over the next years.
• Analysts expect revenue to grow about 24.7% a year over the next years.
• Analysts expect the net margin to improve by 4.4 points from today's 5.6%.
• Revenue grew 33.4% a year over the last 3 years.

Next earnings report: 2026-12-02

Similar companies

7741.T · APOLLOHOSP.NS · DRREDDY.NS · ZYDUSLIFE.NS · CIPLA.BO · 4151.T

Questions

What grade does Lenskart Solutions Limited (LENSKART.BO) have?

In our weekly check, Lenskart Solutions Limited is graded B (A to F). Of 19 checks on debt, profit, cash flow and trend: 15 pass, warnings: 2, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of LENSKART.BO stock?

This week's biggest flags for Lenskart Solutions Limited: Weak interest cover, High P/E, Thin margins. In total 4 of 19 checks show a warning or a red flag.

What does Lenskart Solutions Limited do?

Lenskart Solutions Limited is a Healthcare company (Medical - Specialties) based in India, listed on BSE as LENSKART.BO.

When does Lenskart Solutions Limited report earnings next?

The next earnings report is expected on 2026-12-02. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis